In Brief: EchoCath/Medtronic
This article was originally published in The Gray Sheet
Executive Summary
EchoCath/Medtronic: Forge strategic alliance for the development of an ultrasound-guided heart pacemaker implantation system. Under an exclusive license agreement, Medtronic gains access to certain EchoCath technologies "to enable the precise positioning with conventional ultrasound imaging systems of pacemaker leads within the heart," EchoCath says. In exchange, Medtronic will make milestone payments to EchoCath and pay royalties on product sales. The system under development "is designed to augment and, in appropriate cases, replace the traditional fluoroscopy to guide placement of leads"...